News & Resources

Engaging KOLs Online: How to Stay Connected With Medical Experts

Key opinion leaders (KOLs) play a vital role in pharma and biotech companies. The most successful organizations rely on regular feedback from qualified experts. Incorporating feedback into your business strategy gives your company an edge. Expert guidance helps your organization reach its goals and avoid costly pitfalls.

Still, forging connections with renowned clinical experts isn’t always easy. In a post-COVID world, outreach can be a special challenge. Many organizations prefer face-to-face meetings, but virtual meetings are here to stay and many experts have grown to prefer digital contacts. Now is the time to refine your virtual outreach strategy and make the most of digital tools. Read on to learn more.

The Value of KOLs
KOLs are the ultimate subject matter experts; the most sought-after experts have decades of medical experience. Best of all, they have on-the-ground knowledge of treatment patterns and patient preferences. Their insights can help your company streamline operations—they can help guide your organization’s R&D, marketing, and PR efforts. Companies that don’t seek feedback from KOLs make a costly mistake.

Engaging with KOLs early and often helps build interest and trust. The right outreach efforts keep KOLs informed and invested in your company. They also help you spot potential problems early on.

KOL Outreach Tips
Consider the following tips for connecting with KOLs online:

Leverage advisory boards to connect with clinical experts
The current global situation has made KOL engagement difficult but not impossible. By now, many KOLs are used to virtual contacts. A growing number of digital resources are available to keep your company connected. Online advisory boards are one of the most valuable tools in your arsenal; these tools allow your company to contact a curated team of experts.

With online advisory boards, your team can communicate with KOLs 24/7. You can ask questions, seek feedback, and get professional input from medical experts. KOLs provide ongoing responses throughout the day. These tools provide the feedback you need—without expensive or risky travel.

Choose a partner with robust digital platform capabilities
During the spring, many conferences and conventions were pushed online, and companies scrambled to shift their outreach efforts onto a virtual platform. The results were predictably uneven. While some companies managed to create workable online tools, others floundered.

If your organization is still struggling with shaky technology or uneven results, it’s time to reassess—invest in a high-quality virtual platform that allows for in-depth collaboration. Many vendors already have comprehensive virtual platforms in place, and the best vendors already partner with medical experts across the globe. They can offer access to an extensive network of experts and prescribing physicians.

Look for flexible discussion tools
When choosing a platform, consider your options for communication tools. The best platforms let participants engage in rich discussions, but some platforms may not support in-depth dialogue between participants. Avoid digital tools that focus on static, scripted conversations, and steer away from tools that only offer a limited range of discussion forums. Instead, look for a platform that lets participants have free-form discussions.

Seek out experienced vendors
Choosing the right platform isn’t always easy, but your company can streamline this process by creating a detailed checklist. First, look for a vendor that specializes in the healthcare field. Generic virtual collaboration platforms offer a limited range of tools. Privacy and security can also be a significant concern.

Vendors that specialize in serving medical companies know how to handle these obstacles. They can offer a flexible range of tools, designed with pharma and biotech companies in mind. Specialized vendors also understand that medical organizations have special needs such as detailed reports and comprehensive data streams. Their platforms are designed to support and reinforce your research efforts.

The right vendor also offers access to a curated team of specialists. Choosing a vendor with an established group of experts helps streamline your outreach efforts. There’s no need to make individual contacts; instead, your team can log on and get immediate access to KOLs.

ONCOBOARD
ONCOBOARD is Aptitude Health’s collaborative online community platform. With ONCOBOARD, your team has access to many oncology and hematology experts. Members can use a wide range of discussion tools and receive rapid responses from qualified experts. Our state-of-the-art insight reports let your company quickly analyze feedback. ONCOBOARD provides the up-to-date information your organization needs, in one convenient online tool.

Therapeutic Area

Archives

Matthew Gordon

VP, Real-World Evidence
Matthew has more than 25 years of experience in real-world evidence and observational, non-interventional research. He has led studies across the full life cycle—from startup through publication—supporting objectives that range from understanding a disease’s natural history to fulfilling global safety surveillance requirements. Matthew brings deep expertise in orphan disease programs, having overseen more than 25 long-term, global initiatives, as well as in disease and product registries, prospective pharmacoeconomic studies, and systematic literature reviews. Matthew leads the RWE Registries team, responsible for building the business and team. Prior to joining Aptitude Health, he held senior leadership roles at Parexel, Worldwide Clinical Trials, inVentiv Health Clinical, Quintiles Outcome, and ICON Clinical Research. Matthew holds a BA in sociology from Boston University, is a long-standing member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and is a frequent speaker at ISPOR, the Center for Business Intelligence, and related industry conferences.

Gerald Stanvitch, PhD

VP, Scientific Content

Cate Browning, PhD

VP, Global Medical Affairs

Erin Zingales Rau

VP, Account Services

Kelly Kocor

VP, People & Culture
Kelly leads both the human resources and talent acquisition teams, ensuring that Aptitude Health attracts, retains, and develops top personnel to drive our continued success. With over 17 years of experience transforming global HR initiatives, Kelly is an expert in harmonizing HR policies and fostering a culture of engagement and partnership. She is committed to partnering with all areas of the business to ensure full regulatory compliance and delivering value-added services to our organization and its people. Kelly is passionate about developing and implementing HR strategies that help support our employees’ professional and personal growth. She is dedicated to fostering a culture that encourages innovation, collaboration, and inclusivity, helping Aptitude Health continue to be a great place to work.

Bart Zygmond

VP, Finance
Bart brings a wealth of experience to the organization, having worked in the life sciences, pharmaceuticals, manufacturing, and service industries. With his expertise in financial reporting, US GAAP, SOX, cash flow modeling, and financial analysis, he plays a crucial role in the company’s financial management and strategy. Prior to joining Aptitude Health as VP, Finance, Bart held several controller positions: at Q2 Solutions, he oversaw the global finance team and financial operations, ensuring the accurate and timely financial reporting of the company. He also held controller positions at Domtar Inc and Veristat.

Eugene Vissers, MD

Senior VP, Global Scientific Content
Eugene is a seasoned medical doctor with over 20 years of international experience in pharma, consultancy, and agency environments. Eugene leads the US team of dedicated experts responsible for developing high-quality medical content. Prior to joining Aptitude Health, Eugene served as medical director at Ipsen and AstraZeneca. With both his medical degree and an MBA, Eugene brings a unique perspective to his role. His clinical background, combined with his business acumen, allows him to develop innovative strategies that drive results. Under Eugene’s leadership, the medical content team delivers scientific information of the highest quality, providing valuable insights to our clients around the world.

Adrian Barfield

VP, US Business Development

Kelley Hernandez

Executive VP, US Business Development
Kelley has over 18 years of experience in the oncology space. Kelley joined Aptitude Health after working with Cardinal Health, where she was part of the Healthcare and Analytics Division, and finished her tenure there with VitalSource™ (GPO division). As the leader of the strategic business development team for the US, Kelley brings a wealth of expertise to the organization. Her experience in the healthcare industry, combined with her ability to identify and capitalize on new business opportunities, is invaluable in driving the company’s growth and success. Kelley’s dedication to building strong relationships with life science partners is a testament to her commitment to delivering exceptional value to the healthcare industry.

Adam Sinensky, MBA

Chief Technology Officer

Adam has over 20 years of experience in the healthcare industry and an MBA in healthcare management. After 10 years as a strategy consultant to life science companies, Adam has spent the last decade as a product and strategy leader focused on bringing technology products to market across the payor, provider, and life sciences segments. By combining his business acumen and experience working directly with software developers, engineers, and data scientists, Adam has successfully led numerous product launches and enhancements from ideation to development and go-to-market initiatives. His product and change management expertise has led organizational shifts from services to technology at companies such as Change Healthcare and Datavant/Ciox. At Aptitude Health, Adam is responsible for growing our portfolio of product offerings by leveraging real-world data and artificial intelligence with our existing solutions and industry-leading Axess Network of healthcare providers. He also oversees our IT and cybersecurity teams.

Stefanie Daniels

Chief Commercial Officer

Stefanie is a seasoned healthcare executive with over 20 years of experience in oncology. She brings a wealth of knowledge and expertise to the organization. Stefanie joined Aptitude Health after spending over a decade as a senior director at Physicians’ Education Resource, an oncology CME vendor. During her tenure, she led and managed teams responsible for grant development/acquisition, program creation/execution, and faculty management. Stefanie’s deep understanding of the oncology industry and her ability to lead teams through complex projects make her a vital part of the organization’s success. Her dedication to providing high-quality solutions to our life science partners is a testament to her commitment to improving cancer patient care.

Jason Cash

Chief Financial Officer

Jason is an accomplished finance professional with over 20 years of experience in the pharmaceutical services industry. Throughout his career, he has demonstrated a keen ability to navigate high-growth organizations, delivering exceptional results. Before joining Aptitude Health, Jason served as the CFO of Veristat International, a global contract research organization. In this role, he led the financial strategy and played a pivotal role in driving the company’s growth and success. Jason’s wealth of experience and expertise in financial management make him an essential member of the leadership team. His strategic thinking and ability to drive results are highly respected within the industry.

Jez Moulding

Chief Executive Officer
Jez is a seasoned leader with over 20 years of experience in general management and regional president roles. He has a proven track record of success in the healthcare industry, having worked in the US, Japan, Australia, Korea, South Africa, France, and the UK for Sanofi, where he supported the launch of 10 new drugs across various therapeutic areas. As chief commercial officer at UDG Healthcare and EVP at Ashfield, Jez demonstrated his expertise in developing and implementing successful business strategies. He joined Aptitude Health from Pharmaspectra, an IQVIA business, where he served as CEO since 2018. Jez’s extensive experience in the pharmaceutical industry and his leadership skills make him an invaluable asset to the organization.